The OsteoArthritis Centers of America, a global physician consulting and research group providing licensed, proprietary clinical programs, is pleased to announce its partnership with BioD, LLC, a leading regenerative medicine company, located in Memphis, TN.
The OsteoArthritis Centers of America will use the BioDRestore™ Elemental Tissue Matrix to enhance and improve the proprietary algorithm for the treatment of osteoarthritis of the knee. Patient outcomes will be measured in order to show the
effectiveness of using BioDRestore in combination to their proprietary Osteoarthritis treatment algorithms.
About BioD, LLC
BioD, located in Memphis, TN, is a leading regenerative medicine company engaged in the development and commercialization of novel biologic products derived from the placental tissues. Our research and development efforts are focused on the
regenerative potential of amnion and the other placental tissues given their unique biologic structure and the unique immune privilege that characterizes their function in the body. From the recovery of tissue from live, healthy donors during childbirth to the development of new products that will improve patient outcomes, BioD is unlocking the regenerative potential of the human body. For more information, visit our website at www.biodlogics.com.
Statement
Tim Brahm, Chairman and Founder
“ We are very excited to partner with OA Centers of America, a proven leader in advancing the treatment of osteoarthritis. Their strong commitment to developing outcomes driven clinical programs to address osteoarthritis creates a compelling
opportunity to work together. The BioD technology platform is ideally positioned given the unique characteristics of the placental tissues to compliment OA Centers of America proprietary OA treatment regime.
